5 ml solución inyectable en jeringa precargada EFG

DRUG3 trials

Sponsors

Instituto Bernabeu S.L.

Conditions

Women undergoing ovarian stimulation for oocyte donation.low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

Phase 3

Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.

Not yet recruitingCTIS2024-510596-37-01

Instituto Bernabeu S.L.low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

Target: 100Updated: 2025-10-06

Phase 4

Evaluation of the efficacy of micronized natural progesterone (Seidigestan®) vs GnRH antagonists (Astarté®) in the prevention of LH surge during controlled ovarian stimulation: a randomized clinical trial.

RecruitingCTIS2023-504188-18-00

Instituto Bernabeu S.L.Women undergoing ovarian stimulation for oocyte donation.

Start: 2023-11-08Target: 150Updated: 2023-05-09

Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.

WithdrawnCTIS2024-510596-37-00

Instituto Bernabeu S.L.low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

Target: 100Updated: 2024-04-29